A brief overview of the most common histiocytic disorders

Giornale Italiano di Dermatologia e Venereologia

Volumn 145, Issue 6, 2010, Pages 717-731

  Satter, E K ^a   Walters, M C ^a   Hurt, M ^a   Bolton, J G ^a   Dever, T ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Histiocytic sarcoma; Histiocytosis; Histiocytosis, langerhans cell; Histiocytosis, non langerhans cell

Indexed keywords

ACIPIMOX; ADAPALENE; BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CLOBETASOL PROPIONATE; CLOFIBRATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; GEMCITABINE; HYDROXYCHLOROQUINE; IMATINIB; ISOTRETINOIN; MELPHALAN; METHOTREXATE; PREDNISONE; RECOMBINANT INTERFERON; ROSIGLITAZONE; SIMVASTATIN; STEROID; THALIDOMIDE; TUMOR NECROSIS FACTOR INHIBITOR; VINBLASTINE;

ABT LETTERER SIWE DISEASE; ACUTE MONOCYTIC LEUKEMIA; ANEMIA; BENIGN CEPHALIC HISTIOCYTOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CARBON DIOXIDE LASER; CHRONIC MYELOID LEUKEMIA; CRYOGLOBULINEMIA; CRYOTHERAPY; CURETTAGE; DENDRITIC CELL; DERMIS; DIABETES INSIPIDUS; DISEASE ASSOCIATION; DRUG MEGADOSE; EOSINOPHILIC GRANULOMA; ERYTHROCYTE SEDIMENTATION RATE; FOLLICULAR CELL SARCOMA; GENERALIZED ERUPTIVE HISTIOCYTOSIS; HISTIOCYTIC SARCOMA; HISTIOCYTOSIS; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; HYPOCOMPLEMENTEMIA; IMMUNOHISTOCHEMISTRY; INTERDIGITATING DENDRITIC CELL SARCOMA; JUVENILE XANTHOGRANULOMA; LANGERHANS CELL; LANGERHANS CELL SARCOMA; LEUKOPENIA; LOW DRUG DOSE; MULTICENTRIC RETICULOHISTIOCYTOSIS; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NECROBIOTIC XANTHOGRANULOMA; NEUROFIBROMATOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PAPULAR XANTHOMA; PLASMAPHERESIS; PROGNOSIS; PROGRESSIVE NODULAR HISTIOCYTOSIS; PUVA; REVIEW; ROSAI DORFMAN DISEASE; XANTHOMA; XANTHOMA DISSEMINATUM;

EID: 79952335510     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Weitzman S, Egeler RM. Histiocytic disorders of children and adults: introduction to the problem, overview, historical perspective and epidemiology. In: Weitzman S, Egeler RM, editors. Histiocytic disorders of Children and adults. Basic Science, Clinical features and therapy. Cambridge, UK: Cambridge University Press; 2005. p. 1-13.
2. Favara BE, Feller AC. Contemporary classification of histiocytic disorders. The WHO committee on histiocytic/reticulum cell proliferations and the reclassification working group of the Histiocytic Society. Med Pediatr Oncol 1997;29:157-66.
3. Satter EK, Gendernalik SB, Galeckas KJ. Diffuse xanthogranulomatous dermatitis and systemic Langerhans cell histiocytosis: A novel case that demonstrates bridging between non-Langerhans cell histiocytosis and Langerhans cell histiocytosis. J Am Acad Dermatol 2009;60:841-8.
4. Alston RD, Tatevossian RG, McNally RJ, Kelsey A, Birch JM, Eden TO. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr Blood Cancer 2007;48:555-60.
5. Bhatia S, Nesbit ME, Egeler RM, Buckley JD, Mertens A, Robison LL. Epidemiological study of Langerhans cell histiocytosis in children. J Pediatr 1997;130:774-81.
6. Longaker, MA, Frieden IJ, LeBoit PE, Sherertz EF. Congenital "self-healing" Langerhans cell histiocytosis: The need for long-term follow-up. J Am Acad Dermatol 1994;31(5 Pt 2):910-6.
7. Stein SL, Paller AS, Haut PR, Mancini AJ. Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med 2001;155:778-83. (Pubitemid 32613779)
8. Arico M, Girschikofsky M, Généreau T, Klersy C, McClain K, Grois N et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocytic Society. Eur J Cancer 2003;39:2341-8. (Pubitemid 37214858)
9. Munn S, Chu AC, Langerhans cell histiocytosis of the skin. Hematol Clin North Am 1998;12:271-86.
10. Kilpatrick SE, WengerDE, GilchristGS, Shives TC, Wollan PC, Unni KK. Langerhans cell histiocytosis (Histiocytosis X) of bone. Cancer 1995;76:2471-84.
11. Allen CE, McCain KL. Langerhans cell histiocytosis: A review of past, current and future therapies. Drugs Today 2007;43:627-43. (Pubitemid 350004868)
12. Satter EK, High WA. Langerhans Cell histiocytosis: A review of the current recommendations of the histiocyte Society. Pediatr Dermatol 2008;25:291-5. (Pubitemid 351813948)
13. Donadieu J, Piguet C, Bernard F et al. A new clinical score for disease activity in Langerhans cell histiocytosis. Pediatr Blood Cancer 2004;43:770-6. (Pubitemid 39557714)
14. Nanduri VR, Pritchard J, Levitt G, Glaser AW. Long term morbidity and health related quality of life after multisystem Langerhans cell histiocytosis. Eur J Cancer 2006;42:2563-9. (Pubitemid 44444993)
15. Hernandez-Martin A, Baselga E, Drolet B, Esterly N. Juvenile xanthogranuloma. J Am Acad Dermatol 1997;36:355-67.
16. Putnam A, Lowichik A, Coffin C, Pysher T, Bowen A. Juvenile Xanthogranuloma Pathology Case Reviews 2009;14:104-9.
17. Saad N, Skowron F, Dalle S, Forestier JY, Balme B, Thomas L. Multiple Adult Xanthogranuloma: Case Report and Literature Review. Dermatol 2006;212:73-6.
18. Newman B, Hu W, Nigro K, Gilliam A. Aggressive histiocytic disorders that can involve the skin. J Am Acad Dermatol 2007;56:302-16. (Pubitemid 46074235)
19. Tomaszewski M-M, Lupton GP. Unusual expression of S-100 protein in histiocytic neoplasms. J Cutan Pathol 1998;25:129-35. (Pubitemid 28130157)
20. Kraus MD, Haley JC, Ruiz R, Essary L, Morgan Ca, Fletcher CD. "Juvenile" xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol 2001;23:104-11.
21. Chantranuwat C. Systemic form of juvenile xanthogranuloma: Report of a case with liber and bone marrow involvement. Pediatr Dev Pathol 2004;7:646-8.
22. Zelger B, Cerio R, Orchard G, Fritsh P, Wilson-Jones E. Histologic and immunohistochemical study comparing xanthoma disseminatum and histiocytosis X. Arch Derm 1992;128:1207-12.
23. Caputo R, Marzano AV, Passoni E, Berti E. Unusual variants of Langerhans cell histocytoses. J Am Acad Dermatol 2007;57: 1031-45. (Pubitemid 350103618)
24. Calverly DC, Wismer J, Rosenthal D, deSa D, Barr RD. Xanthoma disseminatum in an infant with skeletal and marrow involvement. J Pediatr Hematol Oncol 1995;17:61-5.
25. Seaton ED, Pillai GJ, Chu AC. Treatment of xanthoma disseminatum with cyclophosphamide. Br J Dermatol 2004;150:346-9. (Pubitemid 38352475)
26. Eisendle K, Linder D, Ratzinge G, Zelger B, Philipp W, Piza H et al. Inflammation and lipid accumulation in xanthoma disseminatum: Therapeutic considerations. J Am Acad Dermatol 2006;58:547-9.
27. Gianotti F, Caputo R, Ermacora E, Gianni E. Benign cephalic histiocytosis. Arch Dermatol 1986;122:1038-43.
28. Jih D, Salcedo S, Jaworsky C. Benign cephalic histiocytosis: a case report and review. J Acad Dermatol 2002;47:908-13. (Pubitemid 35403051)
29. Gianotti R, Alessi E, Caputo R. Benign cephalic histiocytosis: a distinct entity or part of a wide spectrum of histiocytic proliferative disorders of children? Am J Dermatopathol 1993;15:315-9.
30. Weston WL, Travers SH, Mierau GW, Heasley D, Fitzpatrick J. Benign cephalic histiocytosis with diabetes insipidus. Pediatric Dermatology 2000;17:296-8.
31. Winkelmann R, Muller S. Generalized eruptive histiocytoma: a benign popular histiocytic reticulosis. Arch Dermatol 1963;88:586-96.
32. Seward J, Malone J, Callen J. Generalized eruptive histiocytosis. J Am Acad Dermatol 2004;50:116-20. (Pubitemid 38095666)
33. Saijo S, Hara M, Kuramoto Y, Tagami H. Generalized eruptive histiocytoma: a report of a variant case showing the presence of dermal indeterminate cells. J Cutan Pathol 1991;18:134-6.
34. Drummond A, Evans C. Multiple self-healing erythematous papules in an adolescent. Arch Dermatol 2003;139:933-8. (Pubitemid 36898934)
35. Repiso T, Roca-Miralles M, Kanitakis J, Castells-Rodellas A. Generalized eruptive histiocytoma evolving into xanthoma disseminatum in a 4-year old boy. Br J Dermatol 1995;132:978-82.
36. Jang K, Lee H, Choi J, Sung K, Koh J, Moon K. Generalized eruptive histiocytoma of childhood. Br J Dermaol 1999;140:174-6.
37. Zelger B, Sidoroff A, Orchard G, Cerio R. Non-langerhans cell histiocytoses: a new unifying concept. Am J Dermatopathol 1996;18:490-504. (Pubitemid 26347270)
38. Klemke C, Dippel E, Geilen C, Koenigsmann M, Thiel E, Orfanos C et al. Atypical generalzided eruptive histiocytosis associated with acute moncytic leukemia. J Am Acad Dermatol 2003;49:233-6.
39. Statham B, Fairris G, Cotterill J. Atypical eruptive histiocytosis - a marker of underlying malignancy? Br J Dermatol 1984;110:103-5.
40. Gibbs NF, O'Grady TC. Progressive eruptive histiocytomas. J Am Acad Dermatol 1996;35:323-5. (Pubitemid 26257269)
41. Caputo R, Crosti C, Cainelli T. A unique cytoplasmic structure in papular histiocytoma. J Invest Dermatol 1977;68:98-104. (Pubitemid 8039303)
42. Gianotti F, Caputo R. Histiocytic syndromes: a review. J Am Acad Dermatol 1985;13:383-404.
43. Torres L, Sanchez JL, Rivera A, Gonzales A. Progressive nodular histiocytosis. J Am Acad Dermatol 1993;29:278-80.
44. Ruiz GA, Ruiz AIB, Fraile HA, Peral Martinez I, García Muñoz M. Progressive nodular histiocytosis accompanied by systemic disorders. Br J Dermatol 2000;143:628-31.
45. Destombes P. Adenitis with lipid excess, in child or young adults, seen in the Antilles and in Mali (4 cases). Bull Soc Pathol Exot Filiales 1965;58:1169-75.
46. Rosai J, Dofrman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 1969;87:63-70.
47. Gaitonde S. Mulifocal extranodal sinus histiocytosis with massive lymphadenopathy: An overview. Arch Pathol Lab Med 2007;131: 1117-21. (Pubitemid 47057903)
48. Lu C, Kuo T, Wong W, Hong H. Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan. J Am Acad Dermatol 2004;51:931-9. (Pubitemid 39593008)
49. Frater JL, Maddox JS, Obadiah JM, Hurley MY. Cutaneous Rosai-Dorfman disease: Comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case. J Cutan Med Surg 2006;10:28-1290.
50. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dofrman disease): review of the entity. Semin Diagn Pathol 1990;7:19-73. (Pubitemid 20075700)
51. Kong Y, Kong J, Shi D, Lu HF, Zhu XZ, Wang J et al. Cutnaeous Rosai-Dorfman disease: a clinical and histopathologic study of 25 cases in China. Am J Surg Pathol 2007;31:341-350. (Pubitemid 46673107)
52. Satter EK, Graham BS, Steger JW. Response of cutaneous Rosai-Dorfman disease to topical and intralesional steroids. Br J Dermatol 2003;149:672-3.
53. Luz FB, Gaspar NK, Gaspar AP, Carneiro S, Ramos-E-Silva M. Multicentric reticulohistiocytosis: a proliferation of macrophages with tropism for skin and joints, part I. Skinmed 2007;6:172-8.
54. Luz FB, Gaspar AP, Ramos-E-Silva M, Carvalho da Fonseca E, Villar EG, Cordovil Pires AR, Kalil-Gaspar N. Immunohistochemical profile of multicentric reticulohistiocytosis. Skinmed 2005;4:71-7.
55. Luz FB, Gaspar NK, Gaspar AP, Carneiro S, Ramos-E-Silva M. Multicentric reticulohistiocytosis: a proliferation of macrophages with tropism for skin and joints, part II. Skinmed 2007;6:227-33.
56. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1980;3:257-70.
57. Fernandez-Herrara J, Pedraz J. Necrobiotic xandiogranuloma. Semin Cutan Med Surg 2007;26:108-13.
58. Bullock JD, Bartley GB, Campbell, Yanes B, Connelly PJ, Funkhouser JW. Necrobiotic xanthogranuloma with paraproteinemia. Case report and a pathogenic theory. Ophthalmol 1986;93:1233-6.
59. Mehregan DA, Winkelmann RK. Necrobiotic xanthogranuloma. Arch Dermaol 1992;128:94-100.
60. Ugurlu S, Bartley GB, Gibson LE. Necrobiotic xanthogranuloma: Long-term outcome of ocular and systemic involvement. Am J Ophthalmol 2000;129:651-7. (Pubitemid 30323733)
61. Finan MC, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases. Medicine 1986;65:376-88.
62. Criado PR, Vasconcellos C, Pegas JR, Lopes LF, Ramos CF, Tebcherani A et al. Necrobiotic xanthogranuloma with lambda paraproteinemia: case report of successful treatment with melphalan and prednisone. J Dermatol Treat 2002;13:87-89. (Pubitemid 34670367)
63. Chave T, Chowdhury M, Holt P. Recalcitrant necrobiotic xanthogranuloma responding to pulsed high-dose oral dexamethasone plus maintenance therapy with oral prednisolone. Br J Dermatol 2001;144: 158-61. (Pubitemid 32154609)
64. Finelli LG, Ratz JL. Plasmapheresis: a treatment modality for necrobiotic xanthogranuloma. J Am Acad Dermatol 1987;17:351-4. (Pubitemid 17128930)
65. Georgiou S, Monastirli A, Kapranos N, Pasmatzi E, Sakkis T, Tsambaos D. Interferon alpha-2a monotherapy for necrobiotic xanthogranuloma. Acta Derm Venereol 1999;24:484-85.
66. Breier F, Zelger B, Reiter H, Gschnait F, Zelger BW. Papular xanthoma: a clinicopathological study of 10 cases. J Cutan Pathol 2002;29: 200-6. (Pubitemid 34615374)
67. Bastida J, Camacho-Galán R, Armesto-Fernández MA, Díaz-Cascajo C. Adult disseminated primary papular xanthoma treated with doxycycline. Arch Dermatol 2007;143:667-9. (Pubitemid 46799869)
68. Kim SH, Koh KJ, Choi JH, Sung KJ, Moon KC, Koh JK. Congenital papular xanthoma. Br J Dermatol 2000;142:569-71.
69. Caputo R, Gianni E, Imondi D, Carminati G, Gianotti R. Papular xanthoma in children. J Am Acad Dermatol 1990;22:1052-6.
70. Chen CG, Chen CL, Liu HN. Primary papular xanthoma of children: a clinicopathologic, immunohistopathologic and ultrastructural study. Am J Dermatopathol 1997;19:596-601.
71. Singla A. Normolipemic papular xanthoma with xanthelasma. Dermatol Online J 2006;12:19.
72. Pileri SA, Grogan TM, Harris NL, Bank P, Campo E, Chan JKC et al. Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathol 2002;41: 1-29.
73. Yang GCH, Besanceney CE, Tam W. Histiocytic sarcoma with interdigitating dendritic cell differentiation: a case report with fine needle aspiration. Cytology and review of literature. Diagn Cytopathol 2009 Oct [Epub ahead of print]
74. Vos JA, Abbondanzo SL, Barekman CL, Andriko JW, Miettinen M, Aguilera NS. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Modern Pathology 2005;18:693-704. (Pubitemid 40676382)
75. Grogan TM, Pileri SA, Chan JKC, Weiss LM, Fletcher CDM. Histiocytic sarcoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO classification of tumors of haematopoietic and lymphoid tissue. Lyon, France: IARC Press; 2008. p. 356-7.
76. De Pas T, Spitaleri G, Pruneri G, Curigliano G, Noberasco C, Luini A et al. Dendritic cell sarcoma: An analytic overview of the literature and presentation of five original cases. Crit Rev Oncol Hematol 2008;65:1-7. (Pubitemid 350216476)
77. Azim HA, Elsedewy E, Azim HA Jr. Imatinib in the treatment of follicular dendritic sarcoma: A case report and review of the literature. Onkologie 2007;30:381-4. (Pubitemid 47013376)
78. Chan JK, Fletcher CDM, Nayler SJ, Cooper, K. Follicular dendritic cell sarcoma: clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997;79:294-313. (Pubitemid 27029894)
79. Chan JKC, Pileri SA, Delsoi G, Fletcher CDM, Weiss LM, Grogg KL. Follicular dendric cell sarcoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et ai, editors. WHO classification of tumors of haematopoietic and lymphoid tissue. Lyon, France: IARCPress; 2008. p. 363-4.
80. Maeda K, Takahashi T, Saitoh C, Watarai K, Wada K, Tajima K et al. Interdigitating Cell Sarcoma. A report of an autopsy case and literature review J Clin Exp Hematopathol 2005;45:37-44.
81. Pillay K, Solomon r, Daubenton JD, Sinclair-Smith CC. Interdigitating dendritic cell sarcoma: a report of four paediatric cases and review of the literature. Histopathology 2004;44:283-91.
82. Gaertner EM, Tsokos M, Derringer GA, Neuhauser TS, Arciero C, Andriko JW. Interdigitating dendritic cell sarcoma. A report of four cases and review of the literature. Am J Clin Pathol 2001;115:589-97. (Pubitemid 32275952)
83. Weiss LM, Grogan TM, Chan JKC. Interdigitating dendritic cell sarcoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissue. Lyon, France: IARCPress; 2008. p. 361-2.
84. Olnes MJ, Nicol T, Duncan M, Bohlman M, Erlich R. Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy. Leuk Lymphoma 2002;43:817-21. (Pubitemid 34428669)
85. BohnOL, Ruiz-Argüelles G, Navarro L, Saldivar J, Sanchez-Sosa S. Cutaneous Langerhans cell sarcoma: a case report and review of the literature. Int J Hematol 2007;85:116-20. (Pubitemid 46365547)
86. Jaffe, R, Weiss LM, Facchetti F. Tumors derived from Langerhans cells. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissue. Lyon, France: IARCPress; 2008. p. 358- 60.
87. Ferringer T, Banks PM, Metcalf JS. Langerhans cell sarcoma. Am J Dermatopathol 2006;28:36-9. (Pubitemid 44366179)